We don't know what we don't know. It all comes down to validation of the tech and an EMA approval will go a very long way in establishing that validation.
That's a fair question and I personally think it's tied to funding. ADXS has proven they'll dilute down here. I think advaxis needs to produce something tangible and accretive to prove they're able to go the long haul. I do think risk/reward is extremely low right now and if/when they strike a reasonable deal, this will take off. How high is another question altogether. Back to the high singles would be nice.
News 
Market Data 
Discover 
